- Reported net income attributable to common stockholders of $0.14 per diluted share
- Reported quarterly normalized funds from operations attributable to common stockholders of $1.45 per diluted share, an increase of 28.3% over the prior year
- Reported total portfolio year-over-year same store NOI (“SSNOI”) growth of 15.0%, driven by SSNOI growth in our Seniors Housing Operating (“SHO”) portfolio of 20.4%
- SHO portfolio organic same store revenue growth increased 9.6% year-over-year in the fourth quarter, resulting from 400 basis points (“bps”) of average occupancy growth and 4.7% growth in Revenue Per Occupied Room (“RevPOR”); SSNOI margin expanded by 270 bps year-over-year
- During the fourth quarter, we completed $13.9 billion of pro rata gross investments, which included the closing of all previously announced acquisitions in the U.K.
- Additionally, we completed $7.5 billion of pro rata dispositions and loan payoffs during the fourth quarter, with volume and pace of activity exceeding prior expectations. Pro rata property dispositions of $6.1 billion included the earlier-than-anticipated sale of the first three tranches of the previously announced Outpatient Medical (“OM”) real estate portfolio in addition to the previously unannounced sale of skilled nursing properties. We also received $1.4 billion in loan repayment proceeds
- Subsequent to year end, we have closed or are under contract to close newly announced pro rata gross investments, exclusive of development funding of $5.7 billion
- During the fourth quarter, we closed our inaugural private fund vehicle, Seniors Housing Fund I, securing approximately $2.5 billion of total equity commitments. Additionally, during the fourth quarter we launched Seniors Housing Debt Fund I
- As of December 31, 2025, reported Net Debt to Adjusted EBITDA of 3.03x and approximately $10.2 billion of available liquidity inclusive of $5.2 billion of available cash and restricted cash and full capacity under our $5.0 billion line of credit
- Expanded the previously announced 10 Year Executive Continuity and Alignment Program to include seven Executive Vice Presidents of Welltower who have agreed to a reduced annual salary and a single, long-term equity-based incentive award which is 75% performance-based. In addition to the five named executive officers of Welltower, the “all-in” incentive structure now encompasses 12 leaders who will receive no additional compensation, beyond a reduced annual base salary and one-time equity-based incentive award
- Reported net income attributable to common stockholders of $1.39 per diluted share
- Reported annual normalized FFO attributable to common stockholders of $5.29 per diluted share, an increase of 22.5% over the prior year
- Meaningfully amplified the Company’s long-term growth trajectory through the completion of $11 billion of pro rata net investments, excluding development funding, anchored by acquisitions of seniors housing communities in the U.S. and U.K. and disposition of lower growth outpatient medical properties
- Announced the next era of our journey, “Welltower 3.0”, underscoring our commitment to modernizing the seniors housing sector through a reimagined customer journey and technology ecosystem, which includes the hiring of Jeff Stott, formerly with Extra Space Storage, as our Chief Technology Officer
- Deepened economic alignment between our shareholders and key operating partners via the introduction of RIDEA 6.0 contracts and creation of the Welltower Fellowship Grant ($10 million annually) to honor the memory of Charles T. Munger and provide direct financial recognition to front-line staff at our best performing seniors housing communities
- S&P Global Ratings (“S&P”) and Moody’s Investor Services, Inc. (“Moody’s”) raised their credit ratings related to Welltower to “A-” with a stable outlook and to “A3” with a stable outlook, respectively
- The Board of Directors approved a 10.4% increase in the quarterly dividend per share, reflecting solid financial performance and the Board’s confidence in the durability of outsized levels of cash flow growth. The dividend is further supported by a low payout ratio and low-levered balance sheet
- $5.2 billion of OM sales, surpassing our initial expectations for the quarter
- $1.4 billion of loan repayments, also representing a pace ahead of our initial expectations
- $0.8 billion of skilled nursing properties as part of our Integra joint venture, which had not previously been contemplated in our disposition guidance as of September 30, 2025
- Same Store NOI: We expect average blended SSNOI growth of 11.25% to 15.75%, which is comprised of the following components:
- Seniors Housing Operating approximately 15.0% to 21.0%
- Seniors Housing Triple-net approximately 3.0% to 4.0%
- Outpatient Medical approximately 2.0% to 3.0%
- Long-Term/Post-Acute Care approximately 2.0% to 3.0%
- Investments: Our earnings guidance includes only those acquisitions announced or closed to date. Furthermore, no transitions, restructures or capital activity beyond those announced to date are included.
- General and Administrative Expenses: We anticipate general and administrative expenses to be approximately $260 million to $270 million. General and administrative guidance and 2026 normalized FFO guidance include anticipated stock-based compensation expense of approximately $60 million, or approximately $0.08 per diluted share.
- Development: We anticipate funding an additional $370 million of development in 2026 relating to projects underway as of December 31, 2025.
- Dispositions: We expect pro rata disposition proceeds of $3.5 billion at a blended yield of 6.8% in the next twelve months. This includes approximately $2.7 billion of consideration from expected property sales and $0.7 billion of expected proceeds from loan repayments.
|
Welltower Inc. Financial Exhibits
|
||||
|
Consolidated Balance Sheets (unaudited) |
||||
|
(in thousands) |
||||
|
December 31, |
||||
|
2025 |
2024 |
|||
|
Assets |
||||
|
Real estate investments: |
||||
|
Land and land improvements |
$ 6,681,131 |
$ 5,271,418 |
||
|
Buildings and improvements |
52,058,099 |
42,207,735 |
||
|
Acquired lease intangibles |
2,845,686 |
2,548,766 |
||
|
Real property held for sale, net of accumulated depreciation |
1,450,137 |
51,866 |
||
|
Construction in progress |
738,859 |
1,219,720 |
||
|
Less accumulated depreciation and intangible amortization |
(10,350,621) |
(10,626,263) |
||
|
Net real property owned |
53,423,291 |
40,673,242 |
||
|
Right of use assets, net |
2,158,045 |
1,201,131 |
||
|
Investments in sales-type leases, net |
497,963 |
172,260 |
||
|
Real estate loans receivable, net of credit allowance |
1,831,210 |
1,805,044 |
||
|
Net real estate investments |
57,910,509 |
43,851,677 |
||
|
Other assets: |
||||
|
Investments in unconsolidated entities |
1,809,590 |
1,768,772 |
||
|
Cash and cash equivalents |
5,033,678 |
3,506,586 |
||
|
Restricted cash |
175,861 |
204,871 |
||
|
Receivables and other assets |
2,373,409 |
1,712,402 |
||
|
Total other assets |
9,392,538 |
7,192,631 |
||
|
Total assets |
$ 67,303,047 |
$ 51,044,308 |
||
|
Liabilities and equity |
||||
|
Liabilities: |
||||
|
Unsecured credit facility and commercial paper |
$ — |
$ — |
||
|
Senior unsecured notes |
16,383,522 |
13,162,102 |
||
|
Secured debt |
2,813,780 |
2,338,155 |
||
|
Lease liabilities |
2,182,993 |
1,258,099 |
||
|
Accrued expenses and other liabilities |
2,719,813 |
1,713,366 |
||
|
Total liabilities |
24,100,108 |
18,471,722 |
||
|
Redeemable noncontrolling interests |
263,223 |
256,220 |
||
|
Equity: |
||||
|
Common stock |
696,621 |
637,002 |
||
|
Capital in excess of par value |
50,898,707 |
40,016,503 |
||
|
Treasury stock |
(14,405) |
(114,176) |
||
|
Cumulative net income |
11,033,569 |
10,096,724 |
||
|
Cumulative dividends |
(20,197,353) |
(18,320,064) |
||
|
Accumulated other comprehensive income |
(287,641) |
(359,781) |
||
|
Total Welltower Inc. stockholders’ equity |
42,129,498 |
31,956,208 |
||
|
Noncontrolling interests |
810,218 |
360,158 |
||
|
Total equity |
42,939,716 |
32,316,366 |
||
|
Total liabilities and equity |
$ 67,303,047 |
$ 51,044,308 |
||
|
Consolidated Statements of Income (unaudited) |
|||||||||
|
(in thousands, except per share data) |
|||||||||
|
Three Months Ended |
Twelve Months Ended |
||||||||
|
December 31, |
December 31, |
||||||||
|
2025 |
2024 |
2025 |
2024 |
||||||
|
Revenues: |
|||||||||
|
Resident fees and services |
$ 2,556,052 |
$ 1,761,878 |
$ 8,452,996 |
$ 6,027,149 |
|||||
|
Rental income |
523,853 |
386,329 |
1,967,935 |
1,570,278 |
|||||
|
Interest income |
54,442 |
71,028 |
246,205 |
256,191 |
|||||
|
Other income |
46,664 |
31,595 |
170,898 |
137,500 |
|||||
|
Total revenues |
3,181,011 |
2,250,830 |
10,838,034 |
7,991,118 |
|||||
|
Expenses: |
|||||||||
|
Property operating expenses |
1,933,932 |
1,409,300 |
6,488,081 |
4,830,211 |
|||||
|
Depreciation and amortization |
594,151 |
480,406 |
2,084,868 |
1,632,093 |
|||||
|
Interest expense |
203,784 |
154,469 |
651,955 |
574,261 |
|||||
|
General and administrative expenses |
1,557,378 |
48,707 |
1,748,435 |
235,491 |
|||||
|
Loss (gain) on derivatives and financial instruments, net |
(5,656) |
(9,102) |
22,407 |
(27,887) |
|||||
|
Loss (gain) on extinguishment of debt, net |
3,089 |
— |
9,245 |
2,130 |
|||||
|
Provision for loan losses, net |
(7,384) |
(245) |
(9,416) |
10,125 |
|||||
|
Impairment of assets |
45,924 |
23,647 |
121,283 |
92,793 |
|||||
|
Other expenses |
125,844 |
34,405 |
201,201 |
117,459 |
|||||
|
Total expenses |
4,451,062 |
2,141,587 |
11,318,059 |
7,466,676 |
|||||
|
Income (loss) from continuing operations before income taxes and other items |
(1,270,051) |
109,243 |
(480,025) |
524,442 |
|||||
|
Income tax (expense) benefit |
4,985 |
(114) |
7,116 |
(2,700) |
|||||
|
Income (loss) from unconsolidated entities |
4,442 |
6,429 |
(14,297) |
(496) |
|||||
|
Gain (loss) on real estate dispositions and acquisitions of controlling interests, net |
1,378,391 |
8,195 |
1,449,043 |
451,611 |
|||||
|
Income (loss) from continuing operations |
117,767 |
123,753 |
961,837 |
972,857 |
|||||
|
Net income (loss) |
117,767 |
123,753 |
961,837 |
972,857 |
|||||
|
Less: Net income (loss) attributable to noncontrolling interests(1) |
21,326 |
3,782 |
24,992 |
21,177 |
|||||
|
Net income (loss) attributable to common stockholders |
$ 96,441 |
$ 119,971 |
$ 936,845 |
$ 951,680 |
|||||
|
Average number of common shares outstanding: |
|||||||||
|
Basic |
689,582 |
625,675 |
665,639 |
602,975 |
|||||
|
Diluted |
710,167 |
634,259 |
679,521 |
608,750 |
|||||
|
Net income (loss) attributable to common stockholders per share: |
|||||||||
|
Basic |
$ 0.14 |
$ 0.19 |
$ 1.41 |
$ 1.58 |
|||||
|
Diluted(2) |
$ 0.14 |
$ 0.19 |
$ 1.39 |
$ 1.57 |
|||||
|
Common dividends per share |
$ 0.74 |
$ 0.67 |
$ 2.82 |
$ 2.56 |
|||||
|
(1) Includes amounts attributable to redeemable noncontrolling interests. |
|||||||||
|
(2) Includes adjustment to the numerator for income (loss) attributable to OP Units and DownREIT Units. |
|||||||||
|
FFO Reconciliations |
Exhibit 1 |
|||||||||
|
(in thousands, except per share data) |
Three Months Ended |
Twelve Months Ended |
||||||||
|
December 31, |
December 31, |
|||||||||
|
2025 |
2024 |
2025 |
2024 |
|||||||
|
Net income (loss) attributable to common stockholders |
$ 96,441 |
$ 119,971 |
$ 936,845 |
$ 951,680 |
||||||
|
Depreciation and amortization |
594,151 |
480,406 |
2,084,868 |
1,632,093 |
||||||
|
Impairments and losses (gains) on real estate dispositions and |
(1,332,467) |
15,452 |
(1,327,760) |
(358,818) |
||||||
|
Noncontrolling interests(1) |
11,940 |
(6,667) |
(13,144) |
(30,812) |
||||||
|
Unconsolidated entities(2) |
32,598 |
27,978 |
137,143 |
129,290 |
||||||
|
NAREIT FFO attributable to common stockholders |
(597,337) |
637,140 |
1,817,952 |
2,323,433 |
||||||
|
Normalizing items, net(3) |
1,625,396 |
78,775 |
1,773,714 |
303,324 |
||||||
|
Normalized FFO attributable to common stockholders |
$ 1,028,059 |
$ 715,915 |
$ 3,591,666 |
$ 2,626,757 |
||||||
|
Average diluted common shares outstanding |
||||||||||
|
For net income (loss) and Normalized FFO |
710,167 |
634,259 |
679,521 |
608,750 |
||||||
|
For NAREIT FFO |
689,582 |
634,259 |
679,521 |
608,750 |
||||||
|
Per diluted share data attributable to common stockholders: |
||||||||||
|
Net income (loss)(4) |
$ 0.14 |
$ 0.19 |
$ 1.39 |
$ 1.57 |
||||||
|
NAREIT FFO |
$ (0.87) |
$ 1.00 |
$ 2.68 |
$ 3.82 |
||||||
|
Normalized FFO |
$ 1.45 |
$ 1.13 |
$ 5.29 |
$ 4.32 |
||||||
|
Normalized FFO Payout Ratio: |
||||||||||
|
Dividends per common share |
$ 0.74 |
$ 0.67 |
$ 2.82 |
$ 2.56 |
||||||
|
Normalized FFO attributable to common stockholders per share |
$ 1.45 |
$ 1.13 |
$ 5.29 |
$ 4.32 |
||||||
|
Normalized FFO payout ratio |
51 % |
59 % |
53 % |
59 % |
||||||
|
Other items:(5) |
||||||||||
|
Net straight-line rent and above/below market rent amortization(6) |
$ (72,863) |
$ (36,259) |
$ (221,708) |
$ (156,460) |
||||||
|
Non-cash interest expenses(7) |
12,995 |
13,731 |
51,230 |
44,335 |
||||||
|
Recurring cap-ex, tenant improvements and lease commissions(8) |
(120,858) |
(81,196) |
(370,693) |
(286,613) |
||||||
|
Stock-based compensation(9) |
18,322 |
9,782 |
58,462 |
41,068 |
||||||
|
(1) Represents noncontrolling interests’ share of net FFO adjustments. |
||||||||||
|
(2) Represents Welltower’s share of net FFO adjustments from unconsolidated entities. |
||||||||||
|
(3) See Exhibit 2. |
||||||||||
|
(4) Includes adjustment to the numerator for income (loss) attributable to OP Units and DownREIT Units. |
||||||||||
|
(5) Amounts presented net of noncontrolling interests’ share and including Welltower’s share of unconsolidated entities. |
||||||||||
|
(6) Excludes normalized other impairment (see Exhibit 2). |
||||||||||
|
(7) Excludes normalized foreign currency loss (gain) (see Exhibit 2). |
||||||||||
|
(8) Reflects recurring cap-ex, tenant improvements and lease commissions on owned operational properties. |
||||||||||
|
(9) Excludes normalized stock compensation expense related to the Ten Year Executive Continuity and Alignment Program, the 2021 Special Performance Option Awards and |
||||||||||
|
Normalizing Items |
Exhibit 2 |
|||||||
|
(in thousands, except per share data) |
Three Months Ended |
Twelve Months Ended |
||||||
|
December 31, |
December 31, |
|||||||
|
2025 |
2024 |
2025 |
2024 |
|||||
|
Loss (gain) on derivatives and financial instruments, net |
$ (5,656) |
(1) |
$ (9,102) |
$ 22,407 |
$ (27,887) |
|||
|
Loss (gain) on extinguishment of debt, net |
3,089 |
(2) |
— |
9,245 |
2,130 |
|||
|
Provision for loan losses, net |
(7,384) |
(3) |
(245) |
(9,416) |
10,125 |
|||
|
Income tax benefits |
(188) |
(4) |
(5,140) |
(8,369) |
(5,140) |
|||
|
Other impairment |
— |
41,978 |
604 |
139,652 |
||||
|
Other expenses |
125,844 |
(5) |
34,405 |
201,201 |
117,459 |
|||
|
Special incentive plan compensation |
1,489,426 |
(6) |
3,576 |
1,497,396 |
33,414 |
|||
|
Casualty losses, net of recoveries |
3,115 |
(7) |
4,926 |
11,367 |
12,261 |
|||
|
Foreign currency loss (gain) |
2,090 |
(8) |
1,913 |
2,088 |
556 |
|||
|
Normalizing items attributable to noncontrolling interests and |
15,060 |
(9) |
6,464 |
47,191 |
20,754 |
|||
|
Net normalizing items |
$ 1,625,396 |
$ 78,775 |
$ 1,773,714 |
$ 303,324 |
||||
|
Average diluted common shares outstanding |
710,167 |
634,259 |
679,521 |
608,750 |
||||
|
Net normalizing items per diluted share |
$ 2.29 |
$ 0.12 |
$ 2.61 |
$ 0.50 |
||||
|
(1) Primarily related to mark-to-market of the equity warrants received as part of the Safanad/HC-One transaction. The warrants were settled in conjunction with the HC-One |
||||||||
|
(2) Primarily related to the extinguishment of secured debt. |
||||||||
|
(3) Primarily related to adjustments to reserves for loan losses under the current expected credit losses accounting standard. |
||||||||
|
(4) Primarily related to the release of valuation allowances. |
||||||||
|
(5) Primarily related to non-capitalizable transaction costs and legal fees. |
||||||||
|
(6) Primarily related to expenses recognized on the Ten Year Executive Continuity and Alignment Program for named executive officers and key employees, the 2021 Special |
||||||||
|
(7) Primarily relates to casualty losses net of any insurance recoveries. |
||||||||
|
(8) Primarily relates to foreign currency gains and losses related to accrued interest on intercompany loans and third party debt denominated in a foreign currency. |
||||||||
|
(9) Primarily relates to hypothetical liquidation at book value adjustments related to in substance real estate investments. |
||||||||
|
Outlook Reconciliation: Year Ending December 31, 2026 |
Exhibit 3 |
||||
|
(in millions, except per share data) |
Current Outlook |
||||
|
Low |
High |
||||
|
FFO Reconciliation: |
|||||
|
Net income attributable to common stockholders |
$ 2,244 |
$ 2,359 |
|||
|
Impairments and losses (gains) on real estate dispositions and acquisitions of controlling interests, net(1) |
(564) |
(564) |
|||
|
Depreciation and amortization(1) |
2,712 |
2,712 |
|||
|
NAREIT and Normalized FFO attributable to common stockholders |
$ 4,392 |
$ 4,507 |
|||
|
Diluted per share data attributable to common stockholders: |
|||||
|
Net income |
$ 3.11 |
$ 3.27 |
|||
|
NAREIT and Normalized FFO |
$ 6.09 |
$ 6.25 |
|||
|
Other items:(1) |
|||||
|
Net straight-line rent and above/below market rent amortization |
$ (289) |
$ (289) |
|||
|
Non-cash interest expenses |
52 |
52 |
|||
|
Recurring cap-ex, tenant improvements and lease commissions(2) |
(459) |
(459) |
|||
|
Stock-based compensation |
63 |
63 |
|||
|
(1) Amounts presented net of noncontrolling interests’ share and Welltower’s share of unconsolidated entities. |
|||||
|
(2) Reflects recurring cap-ex, tenant improvements and lease commissions on owned operational properties. |
|||||
|
SSNOI Reconciliation |
Exhibit 4 |
|||||||
|
(in thousands) |
Three Months Ended |
|||||||
|
December 31, |
||||||||
|
2025 |
2024 |
% growth |
||||||
|
Net income (loss) |
$ 117,767 |
$ 123,753 |
||||||
|
Loss (gain) on real estate dispositions and acquisitions of controlling |
(1,378,391) |
(8,195) |
||||||
|
Loss (income) from unconsolidated entities |
(4,442) |
(6,429) |
||||||
|
Income tax expense (benefit) |
(4,985) |
114 |
||||||
|
Other expenses |
125,844 |
34,405 |
||||||
|
Impairment of assets |
45,924 |
23,647 |
||||||
|
Provision for loan losses, net |
(7,384) |
(245) |
||||||
|
Loss (gain) on extinguishment of debt, net |
3,089 |
— |
||||||
|
Loss (gain) on derivatives and financial instruments, net |
(5,656) |
(9,102) |
||||||
|
General and administrative expenses |
1,557,378 |
48,707 |
||||||
|
Depreciation and amortization |
594,151 |
480,406 |
||||||
|
Interest expense |
203,784 |
154,469 |
||||||
|
Consolidated NOI |
1,247,079 |
841,530 |
||||||
|
NOI attributable to unconsolidated investments(1) |
26,430 |
31,158 |
||||||
|
NOI attributable to noncontrolling interests(2) |
(11,163) |
(15,328) |
||||||
|
Pro rata NOI |
1,262,346 |
857,360 |
||||||
|
Non-cash NOI attributable to same store properties |
(22,971) |
(25,462) |
||||||
|
NOI attributable to non-same store properties |
(590,634) |
(275,531) |
||||||
|
Currency and ownership adjustments(3) |
(6,519) |
1,077 |
||||||
|
Normalizing adjustments, net(4) |
1,119 |
1,995 |
||||||
|
Same Store NOI (SSNOI) |
$ 643,341 |
$ 559,439 |
15.0 % |
|||||
|
Seniors Housing Operating |
469,183 |
389,654 |
20.4 % |
|||||
|
Seniors Housing Triple-net |
75,170 |
73,252 |
2.6 % |
|||||
|
Outpatient Medical |
23,778 |
23,223 |
2.4 % |
|||||
|
Long-Term/Post-Acute Care |
75,210 |
73,310 |
2.6 % |
|||||
|
Total SSNOI |
$ 643,341 |
$ 559,439 |
15.0 % |
|||||
|
(1) Represents Welltower’s interests in joint ventures where Welltower is the minority partner. |
||||||||
|
(2) Represents minority partners’ interests in joint ventures where Welltower is the majority partner. |
||||||||
|
(3) Includes where appropriate adjustments to reflect consistent property ownership percentages, to translate Canadian properties at a USD/CAD rate of 1.43 and to translate |
||||||||
|
(4) Includes other adjustments described in the accompanying Supplement. |
||||||||
|
Reconciliation of SHO SS RevPOR Growth |
Exhibit 5 |
|||
|
(in thousands except SS RevPOR) |
Three Months Ended |
|||
|
December 31, |
||||
|
2025 |
2024 |
|||
|
Consolidated SHO revenues |
$ 2,575,377 |
$ 1,764,329 |
||
|
Unconsolidated SHO revenues attributable to WELL(1) |
53,225 |
66,122 |
||
|
SHO revenues attributable to noncontrolling interests(2) |
(21,043) |
(22,426) |
||
|
SHO pro rata revenues(3) |
2,607,559 |
1,808,025 |
||
|
Non-cash and non-RevPOR revenues on same store properties |
(2,997) |
(2,514) |
||
|
Revenues attributable to non-same store properties |
(1,020,203) |
(372,498) |
||
|
Currency and ownership adjustments(4) |
(18,358) |
(3,953) |
||
|
SHO SS RevPOR revenues(5) |
$ 1,566,001 |
$ 1,429,060 |
||
|
Average occupied units/month(6) |
88,533 |
84,620 |
||
|
SHO SS RevPOR(7) |
$ 5,848 |
$ 5,583 |
||
|
SS RevPOR YOY growth |
4.7 % |
|||
|
(1) Represents Welltower’s interests in joint ventures where Welltower is the minority partner. |
||||
|
(2) Represents minority partners’ interests in joint ventures where Welltower is the majority partner. |
||||
|
(3) Represents SHO revenues at Welltower pro rata ownership. |
||||
|
(4) Includes adjustments to reflect consistent property ownership percentages and foreign currency exchange rates for properties in the U.K. and Canada. |
||||
|
(5) Represents SS SHO RevPOR revenues at Welltower pro rata ownership. |
||||
|
(6) Represents average occupied units for SS properties on a pro rata basis. |
||||
|
(7) Represents pro rata SS average revenues generated per occupied room per month. |
||||
|
Net Debt to Adjusted EBITDA and Adjusted Fixed Charge Ratio Reconciliation |
Exhibit 6 |
||||
|
(in thousands) |
Three Months Ended |
||||
|
December 31, |
|||||
|
2025 |
|||||
|
Net income (loss) |
$ 117,767 |
||||
|
Interest expense |
203,784 |
||||
|
Income tax expense (benefit) |
(4,985) |
||||
|
Depreciation and amortization |
594,151 |
||||
|
EBITDA |
910,717 |
||||
|
Loss (income) from unconsolidated entities |
(4,442) |
||||
|
Stock-based compensation |
1,507,748 |
||||
|
Loss (gain) on extinguishment of debt, net |
3,089 |
||||
|
Loss (gain) on real estate dispositions and acquisitions of controlling interests, net |
(1,378,391) |
||||
|
Impairment of assets |
45,924 |
||||
|
Provision for loan losses, net |
(7,384) |
||||
|
Loss (gain) on derivatives and financial instruments, net |
(5,656) |
||||
|
Other expenses |
125,844 |
||||
|
Casualty losses, net of recoveries |
3,115 |
||||
|
Adjusted EBITDA |
$ 1,200,564 |
||||
|
Total debt(1) |
$ 19,737,446 |
||||
|
Cash and cash equivalents and restricted cash |
(5,209,539) |
||||
|
Net debt |
$ 14,527,907 |
||||
|
Adjusted EBITDA annualized |
$ 4,802,256 |
||||
|
Net debt to Adjusted EBITDA ratio |
3.03x |
||||
|
Interest expense |
$ 203,784 |
||||
|
Capitalized interest |
7,476 |
||||
|
Non-cash interest expense |
(14,546) |
||||
|
Total interest |
196,714 |
||||
|
Secured financing principal amortization |
16,698 |
||||
|
Total fixed charges |
$ 213,412 |
||||
|
Adjusted EBITDA |
$ 1,200,564 |
||||
|
Adjusted fixed charge coverage ratio |
5.63x |
||||
|
(1) Amounts include unamortized premiums/discounts, other fair value adjustments and financing lease liabilities. Excludes operating lease liabilities related to ASC 842 of |
|||||
|
Net Debt to Consolidated Enterprise Value |
Exhibit 7 |
|||||
|
(in thousands, except share price) |
||||||
|
December 31, 2025 |
December 31, 2024 |
|||||
|
Common shares outstanding |
696,507 |
635,289 |
||||
|
Period end share price |
$ 185.61 |
$ 126.03 |
||||
|
Common equity market capitalization |
$ 129,278,664 |
$ 80,065,473 |
||||
|
Total debt |
$ 19,737,446 |
$ 15,608,294 |
||||
|
Cash and cash equivalents and restricted cash |
(5,209,539) |
(3,711,457) |
||||
|
Net debt |
14,527,907 |
11,896,837 |
||||
|
Noncontrolling interests(1) |
1,073,441 |
616,378 |
||||
|
Consolidated enterprise value |
$ 144,880,012 |
$ 92,578,688 |
||||
|
Net debt to consolidated enterprise value |
10.0 % |
12.9 % |
||||
|
(1) Includes all noncontrolling interests (redeemable and permanent) as reflected on our consolidated balance sheet. |
||||||

Source link















Leave a Reply